Health
Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial – The Lancet
In FAVOR III China, among patients undergoing PCI, a QFR-guided strategy of lesionselection improved 1-year clinical outcomes…
We use cookies to help provide and enhance our service and tailor content and ads. To update your cookie settings, please visit the Cookie Preference Center for this site.Copyright © 2021 Elsevier Inc. except certain content provided by third parties. The…
-
Noosa News23 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Noosa News22 hours agoAfter Hours Gallery Visits, French Dining and Garden Illuminations: Your Guide to the Ultimate Melbourne Culture Fix
-
General16 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
Business16 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?